It's been great to talk to Tom Mackenzie of Bloomberg News about the launch of our protein design model and platform this morning!
August 11, 2025 at 8:58 AM
It's been great to talk to Tom Mackenzie of Bloomberg News about the launch of our protein design model and platform this morning!
Starting with macrocycles and mini-binders. Can't wait for your feedback!
More to come! For requests beyond current platform capabilities: partnerships@latentlabs.com.
More to come! For requests beyond current platform capabilities: partnerships@latentlabs.com.
July 22, 2025 at 6:21 AM
Starting with macrocycles and mini-binders. Can't wait for your feedback!
More to come! For requests beyond current platform capabilities: partnerships@latentlabs.com.
More to come! For requests beyond current platform capabilities: partnerships@latentlabs.com.
We’re making Latent-X available with a free tier for commercial and academic users alike.
We want to get cutting-edge AI into the hands of scientists at big pharma and small labs without needing AI teams or infrastructure.
We want to get cutting-edge AI into the hands of scientists at big pharma and small labs without needing AI teams or infrastructure.
July 22, 2025 at 6:21 AM
We’re making Latent-X available with a free tier for commercial and academic users alike.
We want to get cutting-edge AI into the hands of scientists at big pharma and small labs without needing AI teams or infrastructure.
We want to get cutting-edge AI into the hands of scientists at big pharma and small labs without needing AI teams or infrastructure.
What excites me most: getting this into the hands of scientists through our no-code platform. Replicates our validated workflows, no AI background required.
And it’s fast — up to 10x faster than prior methods!
And it’s fast — up to 10x faster than prior methods!
July 22, 2025 at 6:21 AM
What excites me most: getting this into the hands of scientists through our no-code platform. Replicates our validated workflows, no AI background required.
And it’s fast — up to 10x faster than prior methods!
And it’s fast — up to 10x faster than prior methods!
Latent-X generates novel binders from scratch, solving the geometric puzzle of binding at the all-atom level while obeying biochemical rules nature follows.
I'm still mesmerized watching the model generate successful binders directly at the atom level — hydrogen bonds included!
I'm still mesmerized watching the model generate successful binders directly at the atom level — hydrogen bonds included!
July 22, 2025 at 6:21 AM
Latent-X generates novel binders from scratch, solving the geometric puzzle of binding at the all-atom level while obeying biochemical rules nature follows.
I'm still mesmerized watching the model generate successful binders directly at the atom level — hydrogen bonds included!
I'm still mesmerized watching the model generate successful binders directly at the atom level — hydrogen bonds included!
Latent-X achieved breakthrough lab results:
Picomolar binding affinities, directly outperforming prior methods in head-to-head validation.
Leading experimental hit rates:
* 91-100% for macrocycles
* 10-64% for mini-binders
Testing 30-100 designs per target vs millions traditionally.
Picomolar binding affinities, directly outperforming prior methods in head-to-head validation.
Leading experimental hit rates:
* 91-100% for macrocycles
* 10-64% for mini-binders
Testing 30-100 designs per target vs millions traditionally.
July 22, 2025 at 6:21 AM
Latent-X achieved breakthrough lab results:
Picomolar binding affinities, directly outperforming prior methods in head-to-head validation.
Leading experimental hit rates:
* 91-100% for macrocycles
* 10-64% for mini-binders
Testing 30-100 designs per target vs millions traditionally.
Picomolar binding affinities, directly outperforming prior methods in head-to-head validation.
Leading experimental hit rates:
* 91-100% for macrocycles
* 10-64% for mini-binders
Testing 30-100 designs per target vs millions traditionally.
Introducing Latent-X — our all-atom frontier AI model for protein binder design.
State-of-the-art lab performance, widely accessible via the Latent Labs Platform.
Free tier: platform.latentlabs.com
Blog: latentlabs.com/latent-x/
Technical report: tinyurl.com/latent-X
State-of-the-art lab performance, widely accessible via the Latent Labs Platform.
Free tier: platform.latentlabs.com
Blog: latentlabs.com/latent-x/
Technical report: tinyurl.com/latent-X
July 22, 2025 at 6:21 AM
Introducing Latent-X — our all-atom frontier AI model for protein binder design.
State-of-the-art lab performance, widely accessible via the Latent Labs Platform.
Free tier: platform.latentlabs.com
Blog: latentlabs.com/latent-x/
Technical report: tinyurl.com/latent-X
State-of-the-art lab performance, widely accessible via the Latent Labs Platform.
Free tier: platform.latentlabs.com
Blog: latentlabs.com/latent-x/
Technical report: tinyurl.com/latent-X
Apply to access our tools or join the team www.latentlabs.com
February 13, 2025 at 7:00 AM
Apply to access our tools or join the team www.latentlabs.com
Latent Labs comes out of stealth today with $50M funding. Our goal? To push the frontiers of generative biology, giving partners instant access to tools capable of accelerating drug design
February 13, 2025 at 7:00 AM
Latent Labs comes out of stealth today with $50M funding. Our goal? To push the frontiers of generative biology, giving partners instant access to tools capable of accelerating drug design